Industry: Chemical & Material
Published Date: 2026-01-09
Pages: 129 Pages
Report ld: 5618079
Request Sample
Customized Report
Erythromycin Thiocyanate API Market Size(US$)

CAGR 2026-2032
5.5%
Market Size,2032
USD 2,505
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Erythromycin Thiocyanate API market was valued at US$ 1731 million in 2025 and is anticipated to reach US$ 2505 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Erythromycin Thiocyanate API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
The North American market for Erythromycin Thiocyanate API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Erythromycin Thiocyanate API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Erythromycin Thiocyanate API include Yili Chuannig Biotechnology, Yichang East Sunshine, Alebi Pharma, META Pharmaceuticals, Anuh Pharma, HEC Group, AbbVie, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Erythromycin Thiocyanate API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Erythromycin Thiocyanate API. The Erythromycin Thiocyanate API market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Erythromycin Thiocyanate API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Erythromycin Thiocyanate API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Erythromycin Thiocyanate API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Erythromycin Thiocyanate API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Erythromycin Thiocyanate API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Erythromycin Thiocyanate API Market Overview
1.1 Product Definition
1.2 Erythromycin Thiocyanate API by Type
1.2.1 Global Erythromycin Thiocyanate API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Industrial Grade
1.2.3 Feed Grade
1.2.4 Pharmaceutical Grade
1.3 Erythromycin Thiocyanate API by Application
1.3.1 Global Erythromycin Thiocyanate API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Erythromycin Synthesis
1.3.3 Feed Additive
1.4 Global Market Growth Prospects
1.4.1 Global Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Erythromycin Thiocyanate API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Erythromycin Thiocyanate API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Erythromycin Thiocyanate API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Erythromycin Thiocyanate API Production Market Share by Manufacturers (2021–2026)
2.2 Global Erythromycin Thiocyanate API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Erythromycin Thiocyanate API, Industry Ranking, 2024 vs 2025
2.4 Global Erythromycin Thiocyanate API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Erythromycin Thiocyanate API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Erythromycin Thiocyanate API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Erythromycin Thiocyanate API, Product Offerings and Applications
2.8 Global Key Manufacturers of Erythromycin Thiocyanate API, Date of Entry into the Industry
2.9 Erythromycin Thiocyanate API Market Competitive Situation and Trends
2.9.1 Erythromycin Thiocyanate API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Erythromycin Thiocyanate API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Erythromycin Thiocyanate API Production by Region
3.1 Global Erythromycin Thiocyanate API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Erythromycin Thiocyanate API Production Value by Region (2021–2032)
3.2.1 Global Erythromycin Thiocyanate API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Erythromycin Thiocyanate API by Region (2027–2032)
3.3 Global Erythromycin Thiocyanate API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Erythromycin Thiocyanate API Production Volume by Region (2021–2032)
3.4.1 Global Erythromycin Thiocyanate API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Erythromycin Thiocyanate API by Region (2027–2032)
3.5 Global Erythromycin Thiocyanate API Market Price Analysis by Region (2021–2026)
3.6 Global Erythromycin Thiocyanate API Production, Value, and Year-over-Year Growth
3.6.1 North America Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Erythromycin Thiocyanate API Production Value Estimates and Forecasts (2021–2032)
4 Erythromycin Thiocyanate API Consumption by Region
4.1 Global Erythromycin Thiocyanate API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Erythromycin Thiocyanate API Consumption by Region (2021–2032)
4.2.1 Global Erythromycin Thiocyanate API Consumption by Region (2021–2026)
4.2.2 Global Erythromycin Thiocyanate API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Erythromycin Thiocyanate API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Erythromycin Thiocyanate API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Erythromycin Thiocyanate API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Erythromycin Thiocyanate API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Erythromycin Thiocyanate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Erythromycin Thiocyanate API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Erythromycin Thiocyanate API Production by Type (2021–2032)
5.1.1 Global Erythromycin Thiocyanate API Production by Type (2021–2026)
5.1.2 Global Erythromycin Thiocyanate API Production by Type (2027–2032)
5.1.3 Global Erythromycin Thiocyanate API Production Market Share by Type (2021–2032)
5.2 Global Erythromycin Thiocyanate API Production Value by Type (2021–2032)
5.2.1 Global Erythromycin Thiocyanate API Production Value by Type (2021–2026)
5.2.2 Global Erythromycin Thiocyanate API Production Value by Type (2027–2032)
5.2.3 Global Erythromycin Thiocyanate API Production Value Market Share by Type (2021–2032)
5.3 Global Erythromycin Thiocyanate API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Erythromycin Thiocyanate API Production by Application (2021–2032)
6.1.1 Global Erythromycin Thiocyanate API Production by Application (2021–2026)
6.1.2 Global Erythromycin Thiocyanate API Production by Application (2027–2032)
6.1.3 Global Erythromycin Thiocyanate API Production Market Share by Application (2021–2032)
6.2 Global Erythromycin Thiocyanate API Production Value by Application (2021–2032)
6.2.1 Global Erythromycin Thiocyanate API Production Value by Application (2021–2026)
6.2.2 Global Erythromycin Thiocyanate API Production Value by Application (2027–2032)
6.2.3 Global Erythromycin Thiocyanate API Production Value Market Share by Application (2021–2032)
6.3 Global Erythromycin Thiocyanate API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Yili Chuannig Biotechnology
7.1.1 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Company Information
7.1.2 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Product Portfolio
7.1.3 Yili Chuannig Biotechnology Erythromycin Thiocyanate API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Yili Chuannig Biotechnology Main Business and Markets Served
7.1.5 Yili Chuannig Biotechnology Recent Developments/Updates
7.2 Yichang East Sunshine
7.2.1 Yichang East Sunshine Erythromycin Thiocyanate API Company Information
7.2.2 Yichang East Sunshine Erythromycin Thiocyanate API Product Portfolio
7.2.3 Yichang East Sunshine Erythromycin Thiocyanate API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Yichang East Sunshine Main Business and Markets Served
7.2.5 Yichang East Sunshine Recent Developments/Updates
7.3 Alebi Pharma
7.3.1 Alebi Pharma Erythromycin Thiocyanate API Company Information
7.3.2 Alebi Pharma Erythromycin Thiocyanate API Product Portfolio
7.3.3 Alebi Pharma Erythromycin Thiocyanate API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Alebi Pharma Main Business and Markets Served
7.3.5 Alebi Pharma Recent Developments/Updates
7.4 META Pharmaceuticals
7.4.1 META Pharmaceuticals Erythromycin Thiocyanate API Company Information
7.4.2 META Pharmaceuticals Erythromycin Thiocyanate API Product Portfolio
7.4.3 META Pharmaceuticals Erythromycin Thiocyanate API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 META Pharmaceuticals Main Business and Markets Served
7.4.5 META Pharmaceuticals Recent Developments/Updates
7.5 Anuh Pharma
7.5.1 Anuh Pharma Erythromycin Thiocyanate API Company Information
7.5.2 Anuh Pharma Erythromycin Thiocyanate API Product Portfolio
7.5.3 Anuh Pharma Erythromycin Thiocyanate API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Anuh Pharma Main Business and Markets Served
7.5.5 Anuh Pharma Recent Developments/Updates
7.6 HEC Group
7.6.1 HEC Group Erythromycin Thiocyanate API Company Information
7.6.2 HEC Group Erythromycin Thiocyanate API Product Portfolio
7.6.3 HEC Group Erythromycin Thiocyanate API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 HEC Group Main Business and Markets Served
7.6.5 HEC Group Recent Developments/Updates
7.7 AbbVie
7.7.1 AbbVie Erythromycin Thiocyanate API Company Information
7.7.2 AbbVie Erythromycin Thiocyanate API Product Portfolio
7.7.3 AbbVie Erythromycin Thiocyanate API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 AbbVie Main Business and Markets Served
7.7.5 AbbVie Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Erythromycin Thiocyanate API Industry Chain Analysis
8.2 Erythromycin Thiocyanate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Erythromycin Thiocyanate API Production Modes and Processes
8.4 Erythromycin Thiocyanate API Sales and Marketing
8.4.1 Erythromycin Thiocyanate API Sales Channels
8.4.2 Erythromycin Thiocyanate API Distributors
8.5 Erythromycin Thiocyanate API Customer Analysis
9 Erythromycin Thiocyanate API Market Dynamics
9.1 Erythromycin Thiocyanate API Industry Trends
9.2 Erythromycin Thiocyanate API Market Drivers
9.3 Erythromycin Thiocyanate API Market Challenges
9.4 Erythromycin Thiocyanate API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 143
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 95
USD 3950.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 78
USD 4250.00
(Single User License)
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 95
USD 3950.00
(Single User License)
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-03-10
Pages: 89
USD 2900.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 91
USD 2900.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 108
USD 4350.00
(Single User License)
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published Date: 2024-09-25
Pages: 137
USD 4900.00
(Single User License)
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1731 million in 2025 to US$ 2505 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 143
The global Erythromycin Thiocyanate API market size was US$ 1731 million in 2025 and is forecast to reach a readjusted size of US$ 2505 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1731 million in 2025 and is projected to reach US$ 2505 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 95
The global Erythromycin Thiocyanate API market is projected to grow from US$ 1649 million in 2024 to US$ 2387 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
The global Erythromycin Thiocyanate API market size was US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 78
The global market for Erythromycin Thiocyanate API was estimated to be worth US$ 1649 million in 2024 and is forecast to a readjusted size of US$ 2387 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 95
The global market for Erythromycin Thiocyanate API was valued at US$ 1649 million in the year 2024 and is projected to reach a revised size of US$ 2387 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 89
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 91
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 108
Erythromycin thiocyanate active pharmaceutical ingredient (API) refers to the active substance used in the production of erythromycin thiocyanate formulations. It is a salt form of erythromycin, combined with a thiocyanate ion, and has broad-spectrum antibacterial activity, especially against Gram-positive bacteria. This API is used in the pharmaceutical industry for the manufacture of erythromycin-based antibiotics, commonly in both human and veterinary medicine.
Published: 2024-09-25
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now